The chromosomes contain the genome for all plants and animals. Only 5% or so of the entire genome is known because all research has been based on a gravity driven environment. On orbit the situation changes.
This is a very short explanation of a very technical formula by John Wayne Kennedy, Inventor of the formulation.
Ligands in our formulations are formed in an exothermic reaction between a strong acid and base that form a biological complex that binds with the Zinc and Copper ions and carries the minerals to the target area. The particular structure is called a Zinc/Copper Ligands and becomes a highly efficient transport system since the ionic minerals are loosely-bound and therefore are highly bio-available.
To contribute to positive change and achieve our sustainability goals, we partner with many extraordinary organizations around the world. Their expertise enables us to do far more than we could alone, and their passion and talent inspire us. It is our pleasure to introduce you to a handful of the organizations whose accomplishments and commitments are representative of all the organizations we are fortunate to call our partners.
We are currently planning in vitro and in vivo testing to demonstrate efficacy of ionic mineral technology against forms of cancer. The Foundation seeks scientific advisors and researchers interested in participating in this testing. We also welcome interest in other Foundations, medical research institutions, and university partners which wish to explore supporting this research.
The Foundation also would like to help researchers with other promising, novel technologies in the fight against cancer and other diseases. As a minimum, the Foundation will promote such technologies on this site and seek partners and funding to support it.
For more information or to apply for endorsement of the Foundation, please contact us through our inquiry form.
Our bodies need a wide range of micronutrients which we normally obtain from foods in our diet. A theory suggests that particular micronutrient minerals in a bioavailable ionic form will target cancer at the cellular level.
Cancer and other diseased cells often follow an anaerobic metabolic cycle which is less restrictive about micronutrient intake than normal healthy cells. When presented with certain metal ions, John Wayne Kennedy believed that greedy cancer cells take in excessive amounts to the point of metal toxicity and then perish. He theorizes that normal cells which follow the more sophisticated Krebs cycle will absorb only those micronutrient ions that they need and expel the excess.
Kennedy’s first drug candidate utilizes an aqueous mixture of zinc and copper ions, formulated into a cream for topical tests. Remarkably, anecdotal reports of non-clinical testing suggested high efficacy and safety against basal and squamous skin cancers. Suggesting systemic effects, positive results were also reported from topical tests on internal tumors when the cream was applied in the region. Other methods of administration, such as injectables and transdermal patches, could potentially be developed to better deliver this technology to specific locations.
If this theory is proven, this technology may have applications in cancer treatment therapies, detecting small tumors, and preventing tumors by selectively killing cancer cells before tumors form.
An additional area of study is whether these ionic elements act to help the body scavenge free-radicals and reduce oxidative stress, a process known to help prevent and fight cancer formation and proliferation and to help fight aging. Zinc and copper are also important for human proteins that both influence disease defense pathways and upregulate antioxidant enzymes.
The Centers for Disease Control and Prevention (CDC) has confirmed a connection between the routine use of antibiotics in livestock and a growing bacterial resistance to antibiotics that kills at least 23,000 people a year.